Breaking News Instant updates and real-time market news.

BCRX

BioCryst

$6.15

(0.00%)

, IDRA

Idera Pharmaceuticals

$1.38

-0.01 (-0.72%)

16:57
07/10/18
07/10
16:57
07/10/18
16:57

BioCryst jumps, Idera falls after proposed merger terminated

BioCryst Pharmaceuticals (BCRX) announced that it has terminated the previously announced merger agreement with Idera Pharmaceuticals (IDRA) following the BioCryst stockholders' failure to approve the adoption of the merger agreement at the BioCryst Special Meeting of Stockholders held on Tuesday. BioCryst shares rallied over 9% after hours, following the announcement, while Idera shares dropped 7% after hours. BioCryst said it would reimburse Idera for $6M transaction-related expenses as a result of terminating the merger agreement.

BCRX

BioCryst

$6.15

(0.00%)

IDRA

Idera Pharmaceuticals

$1.38

-0.01 (-0.72%)

  • 10

    Jul

  • 10

    Jul

BCRX BioCryst
$6.15

(0.00%)

01/02/18
RBCM
01/02/18
UPGRADE
RBCM
Outperform
BioCryst upgraded to Outperform from Sector Perform at RBC Capital
01/02/18
RBCM
01/02/18
UPGRADE
Target $8
RBCM
Outperform
BioCryst upgraded to Outperform at RBC Capital on BCX7353 performance
As reported earlier, RBC Capital analyst Brian Abrahams upgraded BioCryst to Outperform from Sector Perform and raised his price target to $8 from $6. Abrahams says the lead drug BCX7353 showed a clear reduction in hereditary angioedema attacks in its phase 2 study, while its lack of dose dependence is "legitimately explainable by misidentification of GI side effects at the higher doses". The analyst adds that the recent FDA precedent also implies a "relatively low bar for approvals of drugs to treat rare, potentially fatal diseases".
06/22/18
GHSC
06/22/18
INITIATION
GHSC
Neutral
BioCryst initiated with a Neutral at Seaport Global
Seaport Global initiated BioCryst (BCRX) with a Neutral due to uncertainty on its proposed merger with Idera Pharmaceuticals (IDRA) and views risk/reward as balanced.
06/22/18
06/22/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Sunlands Online (STG) initiated with an Outperform at Credit Suisse. 2. Micron (MU) initiated with a Buy at Benchmark. 3. Interpace Diagnostics (IDXG) initiated with a Buy at Ladenburg. 4. Alteryx (AYX) initiated with an Outperform at Oppenheimer. 5. BioCryst (BCRX) initiated with a Neutral at Seaport Global. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
IDRA Idera Pharmaceuticals
$1.38

-0.01 (-0.72%)

11/09/17
HCWC
11/09/17
INITIATION
Target $4
HCWC
Buy
Idera Pharmaceuticals initiated with a Buy at H.C. Wainwright
H.C. Wainwright analyst Swayampakula Ramakanth started Idera Pharmaceuticals with a Buy rating and $4 price target. The company's two lead products have "significant potential in the fast growing immunotherapy market," the analyst contends.
11/09/17
11/09/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. AnaptysBio (ANAB) initiated with a Buy at Jefferies. 2. Regenxbio (RGNX) resumed with an Overweight at Morgan Stanley. 3. GTx (GTXI) initiated with a Buy at Stifel. 4. Idera Pharmaceuticals (IDRA) initiated with a Buy at H.C. Wainwright. 5. Nektar (NKTR) initiated with a Buy at Canaccord. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
11/09/17
PIPR
11/09/17
NO CHANGE
Target $4
PIPR
Overweight
Piper reiterates Overweight rating on Idera after IMO-2125 trial update
After Idera Pharmaceuticals reported a 5th unconfirmed RECIST response in its ongoing IMO-2125 plus Yervoy combo trial in PD-1 refractory metastatic melanoma, bringing the ORR to 50%, Piper Jaffray analyst Edward Tenthoff reiterated his Overweight rating and $4 price target on the stock, which is up 15% to $2.03 in midday trading.
06/13/18
JMPS
06/13/18
NO CHANGE
Target $4
JMPS
Outperform
Idera Pharmaceuticals price target lowered to $4 from $8 at JMP Securities
JMP Securities analyst Konstantinos Aprilakis lowered his price target on Idera Pharmaceuticals to $4 from $8 after the company's Phase 2 trial of IMO-8400 in the dermatomyositis setting did not meet its primary endpoint. While he views this latest development for IMO-8400 as disappointing, he reminds investors of the positive tilsotolimod data recently presented at ASCO and still thinks tilsotolimod plus ipilimumab has the potential for a favorable competitive profile in the anti PD-1 refractory melanoma setting. Aprilakis keeps an Outperform rating on Idera shares.

TODAY'S FREE FLY STORIES

SBH

Sally Beauty

$15.59

-0.78 (-4.76%)

10:00
07/16/18
07/16
10:00
07/16/18
10:00
Hot Stocks
Sally Beauty falls -4.9% »

Sally Beauty is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Sep

ADS

Alliance Data

$229.04

-14.45 (-5.93%)

10:00
07/16/18
07/16
10:00
07/16/18
10:00
Hot Stocks
Alliance Data falls -5.9% »

Alliance Data is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 08

    Aug

RDY

Dr. Reddy's

$30.50

-2.76 (-8.30%)

10:00
07/16/18
07/16
10:00
07/16/18
10:00
Hot Stocks
Dr. Reddy's falls -8.1% »

Dr. Reddy's is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DWT

Britannia Bulk

$7.20

0.39 (5.73%)

10:00
07/16/18
07/16
10:00
07/16/18
10:00
Hot Stocks
Britannia Bulk rises 5.6% »

Britannia Bulk is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QEP

QEP Resources

$12.34

-0.42 (-3.29%)

10:00
07/16/18
07/16
10:00
07/16/18
10:00
Options
3K Qep Resources Aug 13 - 14 call spreads bought for 33c »

3K Qep Resources Aug 13 -…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 19

    Aug

DB

Deutsche Bank

$12.11

0.865 (7.70%)

10:00
07/16/18
07/16
10:00
07/16/18
10:00
Hot Stocks
Deutsche Bank rises 7.7% »

Deutsche Bank is up 7.7%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARNC

Arconic

$19.17

1.78 (10.24%)

10:00
07/16/18
07/16
10:00
07/16/18
10:00
Hot Stocks
Arconic rises 10.3% »

Arconic is up 10.3%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HMC

Honda

$29.29

-0.01 (-0.03%)

09:55
07/16/18
07/16
09:55
07/16/18
09:55
Downgrade
Honda rating change  »

Honda downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

VFC

VF Corp.

$87.06

2.22 (2.62%)

, PNC

PNC Financial

$139.80

2.46 (1.79%)

09:55
07/16/18
07/16
09:55
07/16/18
09:55
Options
Early notable gainers among liquid option names on July 16th »

Notable gainers among…

VFC

VF Corp.

$87.06

2.22 (2.62%)

PNC

PNC Financial

$139.80

2.46 (1.79%)

C

Citi

$68.39

1.39 (2.07%)

WFC

Wells Fargo

$56.41

1.06 (1.92%)

CFG

Citizens Financial

$40.02

0.66 (1.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 18

    Jul

  • 20

    Jul

  • 20

    Jul

  • 26

    Jul

  • 12

    Oct

  • 19

    Oct

  • 14

    Jan

  • 12

    Apr

  • 15

    Apr

  • 13

    Jul

  • 13

    Jul

  • 15

    Oct

  • 15

    Oct

IIIV

i3 Verticals

$16.73

(0.00%)

09:53
07/16/18
07/16
09:53
07/16/18
09:53
Initiation
i3 Verticals initiated  »

i3 Verticals initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$353.66

2.85 (0.81%)

, GOL

Gol Linhas

$6.02

0.17 (2.91%)

09:53
07/16/18
07/16
09:53
07/16/18
09:53
Hot Stocks
Boeing, GOL Airlines sign order for 30 737 MAX 10 airplanes, 15 MAX 8s »

Boeing (BA) and GOL…

BA

Boeing

$353.66

2.85 (0.81%)

GOL

Gol Linhas

$6.02

0.17 (2.91%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

  • 25

    Jul

ASML

ASML

$199.55

0.32 (0.16%)

09:50
07/16/18
07/16
09:50
07/16/18
09:50
Upgrade
ASML rating change  »

ASML upgraded to Positive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

HFC

HollyFrontier

$68.71

0.05 (0.07%)

09:50
07/16/18
07/16
09:50
07/16/18
09:50
Options
HollyFrontier calls active »

HollyFrontier calls…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

09:50
07/16/18
07/16
09:50
07/16/18
09:50
General news
U.S. corporate bond update: issuance should pick up this week »

U.S. corporate bond…

VUZI

Vuzix

$7.60

(0.00%)

09:47
07/16/18
07/16
09:47
07/16/18
09:47
Hot Stocks
Vuzix receives M300 Smart Glasses follow-on order from AMA »

Vuzix Corporation is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XON

Intrexon

$14.43

-0.95 (-6.18%)

09:47
07/16/18
07/16
09:47
07/16/18
09:47
Hot Stocks
Intrexon falls -7.7% »

Intrexon is down -7.7%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RDY

Dr. Reddy's

$30.37

-2.89 (-8.69%)

09:47
07/16/18
07/16
09:47
07/16/18
09:47
Hot Stocks
Dr. Reddy's falls -8.3% »

Dr. Reddy's is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AOI

Alliance One

$16.40

(0.00%)

09:47
07/16/18
07/16
09:47
07/16/18
09:47
Hot Stocks
Alliance One falls -8.8% »

Alliance One is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

OFG

OFG Bancorp

$14.55

(0.00%)

09:47
07/16/18
07/16
09:47
07/16/18
09:47
Hot Stocks
OFG Bancorp rises 6.2% »

OFG Bancorp is up 6.2%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jul

  • 31

    Jul

DB

Deutsche Bank

$11.96

0.72 (6.41%)

09:47
07/16/18
07/16
09:47
07/16/18
09:47
Hot Stocks
Deutsche Bank rises 6.4% »

Deutsche Bank is up 6.4%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARNC

Arconic

$19.70

2.31 (13.28%)

09:47
07/16/18
07/16
09:47
07/16/18
09:47
Hot Stocks
Arconic rises 13.2% »

Arconic is up 13.2%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:45
07/16/18
07/16
09:45
07/16/18
09:45
General news
Business Inventories to be reported at 10:00 »

May Business Inventories…

TGI

Triumph Group

$20.10

(0.00%)

09:41
07/16/18
07/16
09:41
07/16/18
09:41
Hot Stocks
Triumph Group awarded contract with Saab »

Triumph Group announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

  • 08

    Aug

FCEL

FuelCell

$1.33

(0.00%)

09:41
07/16/18
07/16
09:41
07/16/18
09:41
Conference/Events
FuelCell management to meet with Roth Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

PAAS

Pan American Silver

$16.89

(0.00%)

09:40
07/16/18
07/16
09:40
07/16/18
09:40
Downgrade
Pan American Silver rating change  »

Pan American Silver…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.